A raging issue on the first day of XVIII International AIDS Conference was whether Isoniazid (INH) Preventive Therapy (IPT) be given to all - regardless whether people have TB or not? A full-course of IPT can prevent latent tuberculosis (TB) infection from becoming active TB disease. It is very crucial and often life-saving for people living with HIV (PLHIV) who are co-infected with tuberculosis (TB) as TB continues to be the biggest killer of PLHIV...

A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bacterial infection. "We're ...

Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's ...

The European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) have published their jointly developed European Union Standards for Tuberculosis Care (ESTC). The 21 patient-centred standards aim to guide clinicians and public health workers to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in ...

A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) - a disease that kills 2 million people annually - a scientist reported at the 243 National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications ...

The rate of new TB (tuberculosis) cases in the USA in 2011 was the lowest since 1953, when official records began, says a new report issued by MMWR (Morbidity and Mortality Weekly Report), CDC. The 2011 rate of 3.4 cases per 100,000 people was 6.4% lower than the previous ...

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the ...

According to the World Health Organization (WHO), one-third of the world's population is currently infected with tuberculosis bacteria. The bacteria is incredibly resistant to treatment, and despite its prevalence, very little is known about why it is so stress tolerant. But, researchers at the University of Pittsburgh have been developing ...